A batch of muscle relaxant tablets has been recalled because the bottles may contain a higher dosage than listed on the label. The company notes in its recall advisory that taking too much of this drug may result in excessive depression of the central nervous system, potentially causing issues that can include fainting, falling, coma, seizures, and death.
Hearing aids could become far more affordable in the US, with the FDA proposing a new category of over-the-counter models potentially far cheaper than current, prescription hearing aids. The new rule would upend current legislation that requires hearing aids be fitted by an audiologist, and only after a medical exam is completed.
A unique lung cancer case has prompted a call for additional research into the popular cannabinoid CBD as a potential cancer treatment, according to a newly published report in BMJ Case Reports. Though more research is needed, CBD has grown in popularity as a medicinal compound, with user reports claiming effects like reduced inflammation, a decrease in pain, improvements in some mental health symptoms, and similar.
Your genes may play a big role in the results you see from exercise, according to a new study from Anglia Ruskin University. The researchers say certain genes have a "significant role" in how one's body responds to exercise, including results that revolve around cardiovascular fitness, muscle strength, and anaerobic power.
We've known for a while now that McDonald's is testing its own plant-based burger offering called the 'McPlant,' but it has thus far been unavailable for consumers in the US to try. That changes starting early next month when McDonald's will begin testing the McPlant at select restaurants across the nation. Because this is only a test run, the burgers will be available for a limited time.
Researchers with the University of California have found that diets mimicking fasting offer health benefits in mice, at least when followed regularly on five-day cycles. The faux fasting diet helped counteract the health impact of the high-calorie and high-fat diet fed to the mice, which were split into three groups and studied for more than two years.
Only a day after recommending an emergency use authorization for Moderna's booster vaccine dose, the FDA panel of advisers is back with a similar recommendation for Johnson & Johnson's Janssen COVID-19 vaccine. The committee unanimously voted in favor of granting J&J an emergency use authorization, though the terms under which the booster would be offered differs from the EUA granted to Pfizer.
The FDA has published a new recall advisory from Lupin Pharmaceuticals over two different drugs: Hydrochlorothiazide and Irbesartan. The company, which stopped marketing these particular drugs in January, says it is recalling the batches due to potentially higher than acceptable levels of an impurity called N-nitrosoirbesartan.
A chemical found in many consumer cosmetic and plastic products may be responsible for around 100,000 premature deaths in the US every year, according to a new study from NYU Langone Health. Phthalates, which are a group of plasticizers, can be found in many soaps, shampoos, hair spray products, nail polish, food packaging, and even plastic toys.
Butterball, the poultry company best known for its frozen turkeys, has announced a new turkey product recall over potential contamination with plastic. The announcement comes only a few weeks ahead of Thanksgiving, but shouldn't impact turkey availability for the holiday -- the issue impacts ground turkey products, not whole birds.
A new study explores the link between certain viral infections during one's youth and the onset of multiple sclerosis (MS) later in life. The autoimmune disease cannot be cured and though studies have shed light on how the condition may come about, there are still many mysteries that need to be unraveled.
A Food and Drug Administration advisory panel has unanimously recommended granting emergency use authorization for a third Moderna shot, though only some people would be eligible for the booster shot. The recommendation follows Moderna's second-quarter financial details shared in August, which included information on the COVID-19 vaccine's efficacy six months after the second dose, as well as the booster for its booster shots to help protect against SARS-CoV-2 variants.